Feature | n | |
---|---|---|
Sex, male (%) | 20/25 (80%) | 25 |
HIV-1 subtype B (%) | 25/25 (100%) | 25 |
Plasma HIV-1 RNA, log10 copies/mL [mean (SD)] | 4.17 (1.11) | 22 |
CD4 + T-Cell count, cells/mm3 [mean (SD)] | 328.5 (217.07) | 12 |
RAL exposure time, months [mean (SD)] | 22.33 (20.38) | 15 |
Time on ART, years [mean (SD)] | 10.65 (5.7) | 12 |
Total prior ART regimens [mean (SD)] | 5.31 (3.13) | 16 |
Optimized backbone regimen (%) | 17 | |
NRTIs | 5/17 (29.41%) | 17 |
NRTIs + PI | 5/17 (29.41%) | 17 |
NNRTIs + PI | 3/17 (17.65%) | 17 |
NRTIs + NNRTIs | 1/17 (5.88%) | 17 |
Othera | 3/17 (17.65%) | 17 |